<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00528515</url>
  </required_header>
  <id_info>
    <org_study_id>AMG-NKEBN/364-A/2005</org_study_id>
    <nct_id>NCT00528515</nct_id>
  </id_info>
  <brief_title>Desflurane Versus Propofol Anesthesia for Off-Pump CABG</brief_title>
  <official_title>Comparison of Desflurane and Propofol Anesthesia for Off-Pump Coronary Artery Bypass Grafting Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Gdansk</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Gdansk</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to prove if anesthesia maintained with the inhaled volatile
      anesthetic desflurane is superior to the intravenously applied propofol anesthesia in
      off-pump coronary artery bypass grafting (OP-CABG) surgery as measured by following
      parameters:

        1. hemodynamic parameters during and after the operation,

        2. pulmonary gas exchange, need for mechanical ventilation and for ICU and intrahospital
           stay,

        3. release of heart muscle injury markers in response to surgery and intraoperative
           ischaemia,

        4. inflammatory response to the operation.

      We suspect that insufflation anesthesia with desflurane may be superior to intravenous
      anesthesia with propofol.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      General anesthesia will be induced by intravenous dosis of fentanyl, vecuronium and etomidate
      and further maintained either by inhaled desflurane or propofol infusion, with concomitant
      empirically administered fentanyl doses and continuous infusion of vecuronium.

      After induction of anesthesia a Swan-Ganz catheter for continuous cardiac output, right
      ventricle end diastolic volume and blood saturation measurements will be introduced through
      the internal jugular vein. A transesophageal echocardiography probe will be placed
      additionally for the Tei-index measurement.

      Hemodynamic parameters will be recorded at the following time points:

        -  before induction

        -  after induction

        -  during trachea intubation

        -  before skin incision

        -  3 Min. after skin incision

        -  after sternotomy

        -  before heart positioning for graft placing

        -  before finishing placing each distal anastomoses

        -  10, 20, 30, 40 min after placing the last anastomoses

        -  10 Min. after admission to ICU, 6, 12, 18 and 24 hours after surgery.

        -  TEE measurements will be obtained after sternotomy and 20 Min after placing the last
           distal anastomoses.

      The results will be compared while using the parametric ANOVA test for normally distributed
      continuous data or the nonparametric Kruskal-Wallis/Wilcoxon-U test for categoric or
      inhomogeneous distributed continuous data.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2007</start_date>
  <completion_date type="Actual">March 2008</completion_date>
  <primary_completion_date type="Actual">March 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Markers of heart muscle injury and inflammation will be compared: troponin I, creatinine phosphokinase and its heart specific fraction, C-reactive protein.</measure>
    <time_frame>within the first 2. days after surgery.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evidence of clinically definite heart infarct confirmed by ECG and/or echocardiography, and heart muscle specific creatinine phosphokinase increase.</measure>
    <time_frame>To discharge from hospital (usually within 7 days)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>propofol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>desflurane</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Diprivan (propofol), Astra-Zeneca</intervention_name>
    <description>continuous intravenous infusion with a dose of 3-5 mg/kg/h</description>
    <arm_group_label>1</arm_group_label>
    <other_name>propofol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Suprane (desflurane), Baxter</intervention_name>
    <description>a vapor concentration of 3-7 vol% is maintained with use of vaporizer and under control of arterial blood pressure, heart rate, and BIS index.</description>
    <arm_group_label>2</arm_group_label>
    <other_name>desflurane</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with coronary artery disease qualified for CABG off-pump surgery

          -  Elective surgery

          -  Signed informed consent

        Exclusion Criteria:

          -  Left ventricle ejection fraction &lt; 30%

          -  Serum creatinine &gt; 2 mg/dL

          -  Emergency surgery

          -  Denied consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Romuald Lango, M.D., Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>Medical University of Gdańsk, Department of Cardiac Anesthesiology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Cadiac Anesthesiology, Medical University of Gdańsk</name>
      <address>
        <city>Gdańsk</city>
        <zip>80-211</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <link>
    <url>http://www.amg.gda.pl/uczelnia/informator/projekty.php?id=327</url>
  </link>
  <reference>
    <citation>Xia Z, Luo T. Sevoflurane or desflurane anesthesia plus postoperative propofol sedation attenuates myocardial injury after coronary surgery in elderly high-risk patients. Anesthesiology. 2004 Apr;100(4):1038-9; author reply 1039-40.</citation>
    <PMID>15087655</PMID>
  </reference>
  <reference>
    <citation>Tritapepe L, Landoni G, Guarracino F, Pompei F, Crivellari M, Maselli D, De Luca M, Fochi O, D'Avolio S, Bignami E, Calabrò MG, Zangrillo A. Cardiac protection by volatile anaesthetics: a multicentre randomized controlled study in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass. Eur J Anaesthesiol. 2007 Apr;24(4):323-31. Epub 2006 Dec 8.</citation>
    <PMID>17156509</PMID>
  </reference>
  <reference>
    <citation>Guarracino F, Landoni G, Tritapepe L, Pompei F, Leoni A, Aletti G, Scandroglio AM, Maselli D, De Luca M, Marchetti C, Crescenzi G, Zangrillo A. Myocardial damage prevented by volatile anesthetics: a multicenter randomized controlled study. J Cardiothorac Vasc Anesth. 2006 Aug;20(4):477-83.</citation>
    <PMID>16884976</PMID>
  </reference>
  <reference>
    <citation>De Hert SG, Cromheecke S, ten Broecke PW, Mertens E, De Blier IG, Stockman BA, Rodrigus IE, Van der Linden PJ. Effects of propofol, desflurane, and sevoflurane on recovery of myocardial function after coronary surgery in elderly high-risk patients. Anesthesiology. 2003 Aug;99(2):314-23.</citation>
    <PMID>12883404</PMID>
  </reference>
  <verification_date>May 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 11, 2007</study_first_submitted>
  <study_first_submitted_qc>September 11, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 12, 2007</study_first_posted>
  <last_update_submitted>May 15, 2008</last_update_submitted>
  <last_update_submitted_qc>May 15, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 16, 2008</last_update_posted>
  <responsible_party>
    <name_title>Romuald Lango MD, PhD</name_title>
    <organization>Medical University of Gdańsk, Dept. of Cardiac Anesthesiology</organization>
  </responsible_party>
  <keyword>anesthesia intravenous</keyword>
  <keyword>propofol</keyword>
  <keyword>anesthesia inhalation</keyword>
  <keyword>desflurane</keyword>
  <keyword>heart surgery</keyword>
  <keyword>coronary artery by-pass off-pump</keyword>
  <keyword>hemodynamic processes</keyword>
  <keyword>anesthesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Desflurane</mesh_term>
    <mesh_term>Isoflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

